Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DTaP-HB-PRP~T vaccine
- Development stage
- Phase 3
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DTaP-HB-PRP~T vaccine is a combined vaccine developed by Sanofi Pasteur. It is designed for immunization in infancy, offering protection against Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, and Haemophilus influenzae type b (Hib) in a single injection. This combination aims to reduce the number of injections required, potentially increasing acceptance and compliance with immunization programs. Clinical trials are investigating its immunogenicity, antibody persistence, and booster effect in healthy infants, as well as its safety profile when administered concomitantly with Oral Polio Vaccine.
- Other names
- DTaP-Hep B-PRP-T Combined VaccineDTaP-HB PRP~T Combined Vaccine
02
Targets
PRP-BCR/TT-TCR (Haemophilus influenzae type b PRP-specific B-cell receptors with tetanus carrier-specific T-cell help)BCR (Immunoglobulin G B Cell Receptor)Diphtheria toxoid-specific B-cell receptors and T-cell receptors
Beyond the preview
Go deeper on DTaP-HB-PRP~T vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DTaP-HB-PRP~T vaccine.